Ofloxacin versus co-trimoxazole in the treatment of typhoid fever in children

Pediatrics International

Volumn 39, Issue 2, 1997, Pages 218-221

  SeÇmeer, GÜlten ^a   Kanra, GÜler ^a   Figen, Gonca ^a   Akan, Özay ^a   Ceyhan, Mehmet ^a   Ecevit, Zafer ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Ofloxacin; Salmonella typhi; Trimethoprim sulfamethoxazole; Typhoid fever

Indexed keywords

COTRIMOXAZOLE; OFLOXACIN;

ANTIBACTERIAL ACTIVITY; ANTIBODY TITER; ARTICLE; BACTERICIDAL ACTIVITY; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; ENTEROBACTERIACEAE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RELAPSE; SALMONELLA PARATYPHI; SALMONELLA TYPHI; TYPHOID FEVER;

ANTI-BACTERIAL AGENTS; CHILD; FEMALE; HUMANS; MALE; OFLOXACIN; TIME FACTORS; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; TYPHOID FEVER;

EID: 0030904346     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.1997.tb03585.x     Document Type: Article

References (13)

1. Zavala TI, Quiroz C., Gutierrez MA, Arias J., Renteria M. Fluoroquinolones in the treatment of typhoid fever and the carrier state. Eur. J. Clin. Microbiol. Infect. Dis. 1991; 10: 334–41.
2. Hannan A. Comparative in vitro activity of enoxacin and other fluoroquinolones against multi-resistant strains of Salmonella typhi. Curr. Med. Res. Opin. 1992; 12: 560–563.
3. Schaad UB. Use of the quinolones in paediatrics. Drugs 1993; 45 (Suppl. 3): 37–41.
4. Chysky V., Kapila K., Hullmann R., Arcieri G., Schacht P. Safety of ciprofloxacin in children: World-wide clinical experience based on compassionate use. Emphasis on joint evaluation. Infection 1991; 19: 289–96.
5. Schaad UB, Stoupis C., Wegwood J., Tschaeppeler H., Vock P. Clinical, radiological and magnetic resonance monitoring for skeletal toxicity in pediatric patients with cystic fibrosis receiving a 3-month course of ciprofloxacin. Pediatr. Infect. Dis. J. 1991; 10: 723–9.
6. Koneman EW. Coke Atlas and Textbook of Diagnostic Microbiology. JB Lippincott, Philadelphia. 1992; 105–84.
7. National Committee for Clinical Laboratory Standards (NCCLS). Performance Standards for Antimicrobial Disc Susceptibility Test. Vol. 10, 4th edn. Villa nova. 1992.
8. Matsubara Y., Murata M., Masuda G., Tsuji M., Negishi M. Clinical research on patients with typhoid and paratyphoid fever. KansenshogakuZasshi 1991; 65: 710–15.
9. Mandal BK. Modern treatment of typhoid fever. J. Infect. 1991; 22: 1–4.
10. Ünal S., Akalin H., Gür D., Baykal M. Clinical efficacy of ofloxacin in the treatment of enteric fever. Eur. J. Clin. Microbiol. Infect. Dis. 1991; Special Issue: 306–7.
11. Johansson CB. Multiple resistant non-typhoid Salmonella. Programme and abstracts of FEMS symposium. Istanbul, Turkey, 1991.
12. Sümerkan B., Inan M., Çaǧlayangil A. et al. Evaluation of antimicrobial susceptibility of clinical isolates of Salmonella. Mikrobiyol. Bült. 1994; 28: 21–6.
13. Farid Z., Hassan A., Wahab MF et al. Trimethoprim-sulfamethoxazole in enteric fevers. BMJ 1970; 3: 323–4.